SyVento and OncoArendi agreement

September 3, 2026

SyVento BioTech will be joining Nordic Life Science Days 2026, taking place on 8-9 September at Kistamässan in Stockholm. Meet our team at the Polish National Pavilion, stand F:12, and explore how an integrated CDMO partner can help move your nucleic acid-based therapy from development toward GMP manufacturing and clinical supply. Nordic Life Science Days […]

August 31, 2026

SyVento BioTech will join DefenceTech Cluster and its partners during MSPO 2026 in Kielce, one of the key defence and security industry events in Central and Eastern Europe. On 10 September 2026, representatives of industry, technology, public administration, research organisations and the defence ecosystem will meet at Targi Kielce to discuss how innovation, available funding […]

August 10, 2026

We are delighted to inform that our ongoing manufacturing partnership with BioResearch Pharma (BRP), supporting the development and production of BRP-007 (psoriasis), moved to the next phase of the technical batch production. BRP is a company developing novel topical dermatological therapies based on repurposing of known and market-authorized active substances. The collaboration between companies covers […]

August 7, 2026

SyVento BioTech is pleased to announce a strategic partnership with nCode, a company specializing in AI-driven mRNA sequence optimization and computational design. Together, we offer biotech and pharmaceutical innovators a more integrated development pathway, from optimized mRNA/LNP design to clinical-ready drug product manufacturing. Complementary Expertise Across the Development Process The partnership combines two highly specialized […]

July 30, 2026

Biotechna and SyVento Biotech entered into a strategic partnership for project „Design and development of nanoparticle RNA based drugs to be used in anti-cancer therapy with the construction of a nanoparticle platform for targeted delivery of therapeutic nucleic acids”. The project is funded by grant from Medical Research Agency (Agencja Badań Medycznych – ABM; ABM/2022/6). […]

July 23, 2026

Interview with Tomasz Piec, Chairman of the Supervisory Board of SyVento BioTech The COVID-19 pandemic, geopolitical instability and disruptions to global supply chains have fundamentally changed the way we think about security. Alongside defence, energy and cybersecurity, biotechnology is increasingly recognised as a strategic capability. Why could the ability to develop and manufacture medicines become […]

June 26, 2026

We are pleased to announce that Syvento will participate in the 10th Central European Congress of Life Sciences – EUROBIOTECH 2026, one of the leading biotechnology and life sciences events in Central Europe. Taking place on 2–3 July 2026 in Kraków, the anniversary edition of the congress will bring together scientists, biotechnology companies, industry leaders, […]

June 19, 2026

BIO International Convention 2026 brings together the global biotechnology community to explore new scientific breakthroughs, strategic partnerships, and opportunities that shape the future of healthcare. This year, SyVento BioTech will join industry leaders in San Diego to connect with biotech innovators, pharmaceutical companies, investors, and technology partners seeking to accelerate the development and commercialization of […]

June 19, 2026

Kielce, Poland – June 2026 SyVento BioTech has joined a group of leading organizations from industry, academia, technology, and critical infrastructure sectors in launching the DefenceTech Cluster / Horizon of Security initiative (Horyzont Bezpieczeństwa). The project aims to strengthen Poland’s technological resilience, strategic autonomy, and innovation capabilities through cross-sector collaboration. The initiative was presented during […]